Citation Impact
Citing Papers
Intraocular Pharmacokinetics of a Crystalline Lipid Prodrug, Octadecyloxyethyl-Cyclic-Cidofovir, for Cytomegalovirus Retinitis
2011
Optical coherence tomography angiography
2017 Standout
Macular ischaemia: a contraindication for anti-VEGF treatment in retinal vascular disease?
2012
A SYSTEMATIC REVIEW OF THE ADVERSE EVENTS OF INTRAVITREAL ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR INJECTIONS
2011
Retinal-Vein Occlusion
2010
RETINAL VASCULAR CYSTOID MACULAR EDEMA
2016
Efficacy of Intravitreal Bevacizumab for Stage 3+ Retinopathy of Prematurity
2011 Standout
Endophthalmitis following intravitreal injections
2011
A Safety Review and Meta-Analyses of Bevacizumab and Ranibizumab: Off-Label versus Goldstandard
2012
Adverse events and complications associated with intravitreal injection of anti-VEGF agents: a review of literature
2013 Standout
Proposed Lexicon for Anatomic Landmarks in Normal Posterior Segment Spectral-Domain Optical Coherence Tomography
2014 Standout
Therapies for Macular Edema Associated with Central Retinal Vein Occlusion
2015
Effect on Intraocular Pressure in Patients Receiving Unilateral Intravitreal Anti-Vascular Endothelial Growth Factor Injections
2011
Ocular Drug Delivery
2010 Standout
Large Subretinal Haemorrhage following Change from Intravitreal Bevacizumab to Ranibizumab
2009
THE PATHOPHYSIOLOGY OF GEOGRAPHIC ATROPHY SECONDARY TO AGE-RELATED MACULAR DEGENERATION AND THE COMPLEMENT PATHWAY AS A THERAPEUTIC TARGET
2016
Incidence of Retinal Pigment Epithelial Tears after Intravitreal Ranibizumab Injection for Neovascular Age-Related Macular Degeneration
2011
Effects and Complications of Bevacizumab Use in Patients with Retinopathy of Prematurity: A Multicenter Study in Taiwan
2010
RETINAL VEIN OCCLUSIONS, FROM BASICS TO THE LATEST TREATMENT
2015
Intravitreal bevacizumab (Avastin) versus ranibizumab (Lucentis) for the treatment of age-related macular degeneration: a safety review
2010
RETINAL PIGMENT EPITHELIAL TEARS IN RANIBIZUMAB-TREATED EYES
2009
Postinjection Endophthalmitis in the Comparison of Age-Related Macular Degeneration Treatments Trials (CATT)
2015
Age-related macular degeneration
2012 Standout
Anti–Vascular Endothelial Growth Factor Pharmacotherapy for Age-Related Macular Degeneration
2008
INCIDENCE OF ACUTE ENDOPHTHALMITIS AFTER INTRAVITREAL BEVACIZUMAB INJECTION IN A SINGLE CLINICAL CENTER
2013
ANATOMICAL CORRELATES TO THE BANDS SEEN IN THE OUTER RETINA BY OPTICAL COHERENCE TOMOGRAPHY
2011
Pharmacotherapy for Neovascular Age-Related Macular Degeneration: An Analysis of the 100% 2008 Medicare Fee-For-Service Part B Claims File
2011
Vascular endothelial growth factor in eye disease
2008 Standout
Age-related macular degeneration and polypoidal choroidal vasculopathy in Asians
2016
Aptamers as targeted therapeutics: current potential and challenges
2016 Standout
CLINICAL CHARACTERISTICS OF ENDOPHTHALMITIS AFTER AN INJECTION OF INTRAVITREAL ANTIVASCULAR ENDOTHELIAL GROWTH FACTOR
2010
Outcomes and Risk Factors Associated with Endophthalmitis after Intravitreal Injection of Anti-Vascular Endothelial Growth Factor Agents
2011
Age-related macular degeneration
2018 Standout
Best practices for treatment of retinal vein occlusion
2012
SYSTEMIC INTERLEUKIN 1β INHIBITION IN PROLIFERATIVE DIABETIC RETINOPATHY
2015
Expression of the angiogenic mediator, angiopoietin-like 4, in the eyes of patients with proliferative sickle retinopathy
2017 StandoutNobel
Emerging therapeutic approaches in the management of retinal angiogenesis and edema
2010
Therapeutic effect of bevacizumab injected into the silicone oil in eyes with neovascular glaucoma after vitrectomy for advanced diabetic retinopathy
2009
Intraocular inflammation following intravitreal injection of bevacizumab
2008
SAFETY OF REPEAT INTRAVITREAL INJECTIONS OF BEVACIZUMAB VERSUS RANIBIZUMAB
2009
Antiangiogene Therapie am vorderen Augenabschnitt
2007
Systemic and Ocular Safety of Intravitreal Anti-VEGF Therapies for Ocular Neovascular Disease
2011
Sustained elevation of intraocular pressure after intravitreal injections of anti-VEGF agents
2010
VEGF in Signaling and Disease: Beyond Discovery and Development
2019 Standout
Inflammation in obesity, diabetes, and related disorders
2022 Standout
Ranibizumab and Bevacizumab for Treatment of Neovascular Age-related Macular Degeneration
2012 Standout
EVALUATION OF MACULAR ISCHEMIA IN EYES WITH BRANCH RETINAL VEIN OCCLUSION
2017
Vitreous Inflammation Associated with Intravitreal Anti-VEGF Pharmacotherapy
2013
Effect of Bevacizumab vs Aflibercept on Visual Acuity Among Patients With Macular Edema Due to Central Retinal Vein Occlusion
2017
EVALUATION OF MACULAR ISCHEMIA IN EYES WITH CENTRAL RETINAL VEIN OCCLUSION
2017
Ranibizumab and Bevacizumab for Neovascular Age-Related Macular Degeneration
2011 Standout
The Risk of Toxic Retinopathy in Patients on Long-term Hydroxychloroquine Therapy
2014 Standout
Retinal Pigment Epithelial Detachments in Age-Related Macular Degeneration: Classification and Therapeutic Options
2011
Works of Franz Prager being referenced
Characteristics of severe intraocular inflammation following intravitreal injection of bevacizumab (Avastin)
2008
EVALUATION OF ANTERIOR CHAMBER INFLAMMATORY ACTIVITY IN EYES TREATED WITH INTRAVITREAL BEVACIZUMAB
2006
Association of Retinal Sensitivity and Morphology during Antiangiogenic Treatment of Retinal Vein Occlusion over One Year
2009
COMPARISON OF 2.5 mg/kg AND 5 mg/kg SYSTEMIC BEVACIZUMAB IN NEOVASCULAR AGE-RELATED MACULAR DEGENERATION
2008
Frühe Effekte nach systemischer und intravitrealer Bevacizumab (Avastin®)-Therapie bei neovaskulärer altersbedingter Makuladegeneration
2006
Effect of systemic bevacizumab therapy on retinal pigment epithelial detachment
2006
Randomised clinical trial of intravitreal Avastin vs photodynamic therapy and intravitreal triamcinolone: long-term results
2009
Intravitreal bevacizumab (Avastin) therapy versus photodynamic therapy plus intravitreal triamcinolone for neovascular age-related macular degeneration: 6-month results of a prospective, randomised, controlled clinical study
2008
Intravitreal Avastin for macular oedema secondary to retinal vein occlusion: a prospective study
2008
Retinal pigment epithelium tears following intravitreal ranibizumab therapy
2007
Intravitreal bevacizumab (Avastin(R)) for macular oedema secondary to retinal vein occlusion: 12-month results of a prospective clinical trial
2008
Imaging of the Retinal Pigment Epithelium in Age-Related Macular Degeneration Using Polarization-Sensitive Optical Coherence Tomography
2010
Intravitreal Bevacizumab Therapy for Neovascular Age-related Macular Degeneration with Large Submacular Hemorrhage
2007
Intraocular Concentrations of Growth Factors and Cytokines in Retinal Vein Occlusion and the Effect of Therapy with Bevacizumab
2009